Embedded entrepreneur initiative (EEI)
Active Definitive Contract Awarded Last action
- Contract number
- HR001126CE019
- Awardee
-
Kairu Therapeutics Inc. UEI J3NYGMYBR6M5
- Awarding agency
-
Defense Advanced Research Projects Agency
Department of Defense
- Obligated
- $350,000
Award facts
- Opportunity
-
- DARPA's Commercial Solutions Opening (DCSO) for Commercial Strategy Solicitation · HR001125RE003 · Posted May 1, 2025
- Contract value 100% obligated
- $350,000.00 Current and potential, with all options
- Completion date 71% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- PSC
- B541 Special Studies/Analysis- Defense
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 15 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Alameda, CA 94501, USA
Award details come from SAM.gov/FPDS.
About this award
Kairu Therapeutics Inc. has been awarded a $350,000 firm fixed-price contract by the Defense Advanced Research Projects Agency (DARPA) to support commercialization efforts under the Embedded Entrepreneur Initiative (EEI). The contract, which commenced on January 30, 2026 and extends through January 29, 2027, funds the hiring of external entrepreneurs to facilitate the transition of innovative technologies derived from DARPA's research and development programs into practical military and civilian applications. The work will be performed in Alameda, California, with no set-aside designation applied to this award.
This engagement stems from DARPA's Commercial Solutions Opening (DCSO) solicitation, which sought proposals for organizations possessing technology rights from prior DARPA R&D efforts. Under the EEI framework, Kairu Therapeutics will undertake commercialization activities spanning competitive analysis, financing planning, market engagement strategies, and regulatory compliance activities across 14 primary task areas. The contract award reflects DARPA's commitment to accelerating the commercialization pathway for promising technologies and represents the agency's ongoing efforts to bridge the gap between defense-focused research and broader market applications.
Quick answers
Who was awarded contract HR001126CE019?
HR001126CE019 was awarded to Kairu Therapeutics Inc. by Defense Advanced Research Projects Agency (Department of Defense) on January 30, 2026.
How much is contract HR001126CE019 worth?
The government has obligated $350,000 on HR001126CE019.
Was contract HR001126CE019 competed?
The extent of competition for HR001126CE019 was competed under sap. The government received 15 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award